Work

Extracellular vesicle-associated microRNAs in pancreatic cancer: therapeutic resistance and translational prospects

Year: 2026
Type: article
Abstract: Pancreatic ductal adenocarcinoma (PDAC) remains difficult to treat because of late diagnosis, desmoplasia, and multiple mechanisms of therapeutic resistance. Extracellular vesicle (EV)-associated microRNAs (miRNAs) have been implicated in communication between PDAC cells and stromal or immune populations. This mini review critically distinguishes three levels of evidence: functional delivery of EV-associated miRNAs to recipient cells, associations between vesicle-associated miRNAs and clinical phenotypes, and non-vesicular or intracellular miRNA observations that provide contextual but not direct evidence of EV-mediated effects. Mechanistic studies implicate stromal miR-21 and miR-106b, tumour-associated miR-155 and miR-210, hypoxia-associated miR-301a and miR-30b-5p, and miR-212-3p in tumour–microenvironment interactions or treatment-related phenotypes, although the strength of causal transfer evidence varies. Plasma, serum and salivary EV-miRNA signatures are being explored for liquid biopsy, but they require prospective validation. Engineered EV-mediated siRNA delivery has reached early clinical evaluation in PDAC; this must not be conflated with clinical validation of EV-based miRNA therapeutics. We integrate mechanistic, biomarker and delivery evidence, emphasizing EV nomenclature, functional-transfer controls, and translational limitations.
Language: English
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234098395
FWCI:
Cites: 35
Cited by:
Related to: 10